Journal Article

Overexpression of PKCα is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model

Xin Lin, Yanni Yu, Huiping Zhao, Yiyun Zhang, Jessica Manela and Debra A. Tonetti

in Carcinogenesis

Volume 27, issue 8, pages 1538-1546
ISSN: 0143-3334
Published online March 2006 | e-ISSN: 1460-2180 | DOI: https://dx.doi.org/10.1093/carcin/bgl002
Overexpression of PKCα is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

We previously reported that stable overexpression of protein kinase C alpha (PKCα) in hormone responsive T47D:A18 breast cancer cells produces a hormone-independent/tamoxifen (TAM)-resistant and 17β-estradiol (E2)-inhibitory phenotype in vivo. Furthermore, overexpression of PKCα in T47D:A18 cells also results in cross-upregulation of PKCs β and δ. In this study, we further characterized the contribution of PKC isozymes α, β and δ to this complex phenotype. To determine whether downregulation of PKCα is sufficient to restore the hormone-dependent phenotype in T47D:A18/PKCα cells, PKCα was selectively knocked down using short hairpin RNA (shRNA). To determine the contribution of PKCβ or δ to the hormone-independent/TAM-resistant and E2-inhibitory phenotype, stable T47D:A18/PKCβ and T47D:A18/PKCδ clones were established. Downregulation of PKCα by shRNA in T47D:A18/PKCα20 cells also resulted in reduced PKCβ protein expression in vitro. Tumors established from a T47D:A18/PKCα/shRNA stable clone exhibit 50% reduction of PKCα protein without concomitant reduction in PKCβ, and exhibit partial reversal of the TAM-resistant and E2-inhibitory phenotype in vivo. Furthermore, stable overexpression of neither PKCβ nor PKCδ in T47D:A18 cells are sufficient to produce hormone-independent growth in vitro or in vivo, nor TAM-resistant and E2-inhibited growth in vivo. Taken together, these results suggest that PKCα is required to impart the TAM-resistant and E2-inhibitory phenotype in vivo.

Journal Article.  5732 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.